Pharma15 Live!
Facilitating the Journey from Patient to Study Participant
The Impact of Dynamic Referral Processing
Matt Kibby and Aaron Fleishman return to the Pharma15 Live! stage to discuss BBK's dynamic referral processing service and how it improves and accelerates the patient enrollment process.
"Our process benefits both patients and sites alike. It unburdens the study staff, creating a better experience for them, while also ensuring patients are responded to more quickly and with better care so their journey is a positive one."
-Matt Kibby, President, Chief Strategy Officer, BBK Worldwide

Read More
Topics:
Pharma15 Live!,
Call Centers,
Matt Kibby,
Aaron Fleishman,
Hybrid Clinical Trials,
Dynamic Referral Processing,
Secondary Prescreening
Getting Decentralized Right
What Matters to Patients
In Part 2 of our two-part interview with Phil Kelly, we delve further into the patient perspective on decentralized clinical trials. We ask Phil Kelly to share his thoughts on patient needs, tools, technologies, and the patient experience.
If you are conducting a decentralized clinical trial or planning for one, this is a must-see segment, with valuable insight to leverage for success.

Read More
Topics:
Patient,
Pharma15 Live!,
Most Viewed,
Patient Voice,
Patient Centric,
Decentralized Clinical Trials,
Phil Kelly
Getting Decentralized Right
What Matters to Patients
We know the industry is ready to embrace decentralized clinical trials. But what about patients? What do they think about decentralized clinical trials? What elements are important to them? And what should sponsors consider when designing such trials?
To dig deep, we spoke one-on-one with Phil Kelly, a bladder cancer patient and advocate. He shares his experience and insight in Part 1 of this two-part series on the patient perspective.

Read More
Topics:
Patient,
Pharma15 Live!,
Most Viewed,
Patient Voice,
Patient Centric,
Decentralized Clinical Trials,
Phil Kelly
One-on-One with BBK Worldwide Director of Tech Experience Dena Raffa
There's no question that digital technology is changing the way we engage with patients and altering expectations for the patient experience. As part of our Pharma15 Live! series, we sat down with BBK's Director of Tech Experience Dena Raffa to get her perspective on current trends.
Raffa has been instrumental in many of BBK's software solutions and digital technologies, and most recently she has led the development of BBK's new patient engagement portal - a first of its kind for clinical trial participants.
Read More
Topics:
Technology,
Patient Experience,
Pharma15 Live!,
Dena Raffa,
Tech Experience
PHARMA15 LIVE!
Coordination to Creation: Initiating a New Study Partnership
We often hear about unburdening patients and site staff during clinical trial participation – but what about unburdening sponsors during the clinical trial lifecycle? As BBK Worldwide® Creative Director for Strategic Services, I assist in prescribing the programs and services that best align with the protocol to support a study’s participants on an individual basis. From there, my team and I work closely with our account executives to seamlessly bring our full-service study support from proposal to coordination to creation.
Read More
Topics:
Pharma15 Live!,
Danielle Frate,
Alexia Medici
Improving Diversity and Inclusion in Clinical Trials
One-on-One with Advarra
Get an IRB's perspective on improving diversity and inclusion in clinical trials by watching our interview with Michele Russell-Einhorn, Chief Compliance Officer and Institutional Official at Advarra.
Read More
Topics:
Pharma15 Live!,
Most Viewed,
Institutional Review Board,
IRB,
Advarra,
Michele Russell-Einhorn,
Jessica Kim,
Diversity,
Inclusion
PHARMA15 LIVE!
How Do Patients Feel About Hybrid
and Decentralized Clinical Trials?
What Are Must-Haves for
a Positive Patient Experience?
Patient advocates take center stage in this Pharma15 Live! overtime segment and share their thoughts on hybrid and decentralized clinical trials.
Moderated by BBK Worldwide Founding Principal Bonnie A. Brescia, this segment continues the conversation from a Patients as Partners Europe panel and answers questions asked by study sponsors in attendance.
Read More
Topics:
Pharma15 Live!,
Patient Voice,
Bonnie A. Brescia,
Patient Perspective,
Patients,
Patients as Partners
What do doctors and nurses think about solutions designed to make clinical trials easier to conduct? Are they helpful? Do they alleviate burdens? And which ones do they prefer?
In this special Pharma15 Live! segment, BBK Worldwide® industry experts Matt Kibby and Aaron Fleishman discuss recent Study Voices survey results that shed light on this topic. They examine doctor and nurse perspectives on services designed to provide support in conducting clinical trials — including services for virtual, hybrid, and decentralized clinical trials.
“We were looking at whether or not doctors and nurses at sites that were conducting clinical trials would appreciate different types of services that assist with their ability to conduct them."
-Matt Kibby, Principal, President, BBK Worldwide
Read More
Topics:
Clinical Trials,
Pharma15 Live!,
Most Viewed,
Study Voices,
COVID-19,
Matt Kibby,
Aaron Fleishman,
Decentralized Trials,
Study Voices 2020,
Hybrid Trials
The Road to Reopening
In our newest Pharma15 Live! episode, Principal of RSG Services Rob Laurens provides guidance on managing clinical trial patient travel as COVID-19 restrictions ease and countries and study sites start to reopen.
Rob answers common questions and highlights the advantages of thoughtful pre-planning and contingency preparation. Watch now and discover strategies clinical trial sponsors can leverage to maximize patient safety and engagement during COVID-19 and beyond.
Download the eBook

Because there's a lot to consider in terms of managing patient travel as COVID-19 restrictions ease, we've captured guidance in a special eBook to download and review at your convenience.
Read More
Topics:
Patient Engagement,
Patient Travel,
Pharma15 Live!,
Patient Enrollment,
COVID-19,
Coronavirus,
Rob Laurens
As the director and one of the producers of Pharma15 Live! I wanted to share with you some insights into what we’ve learned through an amazing three seasons! First of all, if you were to tell me at the beginning of our series that it would even last three seasons, I’d tell you I’d be shocked – but nonetheless here we are and it’s been great!
Read More
Topics:
Pharma15 Live!,
COVID-19,
Matt Kibby,
Aaron Fleishman,
Craig Lipset,
Advarra,
Season Three,
Michele Russell-Einhorn,
Dan Sfera,
Ray Dorsey, MD